Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 24-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler Compared With Placebo in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Brief Summary: The Purpose of this study is to assess the efficacy and safety of two strengths of the FF/GW642444 Inhalation Powder in subject with Chronic Obstructive Pulmonary Disease (COPD)


Options:
A: Arm Label: Fluticasone Furoate Inhalation Powder; Type: EXPERIMENTAL; Interventions: Drug: FF Inhalation Powder | Arm Label: FF Inhalation Pwdr; Type: EXPERIMENTAL; Interventions: Drug: FF Inhalation Powder | Arm Label: Fluticasone Furoate/GW642444 Inhalation Powder; Type: EXPERIMENTAL; Interventions: Drug: FF/GW642444 Inhalation Powder | Arm Label: FF/GW642444 Inhalation Pwdr; Type: EXPERIMENTAL; Interventions: Drug: FF/GW642444 Inhalation Powder | Arm Label: GW642444 Inhalation Powder; Type: EXPERIMENTAL; Interventions: Drug: GW642444 Inhalation Powder | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: FF Inhalation Powder; Assigned to Arm(s): FF Inhalation Pwdr, Fluticasone Furoate Inhalation Powder | Intervention Type: DRUG; Name: FF/GW642444 Inhalation Powder; Assigned to Arm(s): FF/GW642444 Inhalation Pwdr, Fluticasone Furoate/GW642444 Inhalation Powder | Intervention Type: DRUG; Name: GW642444 Inhalation Powder; Assigned to Arm(s): GW642444 Inhalation Powder | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: NVA237 dose 1; Type: EXPERIMENTAL; Interventions: Drug: NVA237 | Arm Label: Long-acting beta 2-agonist (LABA); Type: ACTIVE_COMPARATOR; Interventions: Drug: Long-acting beta 2-agonist (LABA), Drug: Placebo | Intervention Type: DRUG; Name: NVA237; Assigned to Arm(s): NVA237 dose 1 | Intervention Type: DRUG; Name: Long-acting beta 2-agonist (LABA); Assigned to Arm(s): Long-acting beta 2-agonist (LABA) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Long-acting beta 2-agonist (LABA)
C: Arm Label: Indacaterol 150 μg-tiotropium 18 μg-placebo; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 μg, Drug: Tiotropium 18 μg, Drug: Placebo | Arm Label: Tiotropium 18 μg-placebo-indacaterol 150 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 μg, Drug: Tiotropium 18 μg, Drug: Placebo | Arm Label: Placebo-indacaterol 150 μg-tiotropium 18 μg; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol 150 μg, Drug: Tiotropium 18 μg, Drug: Placebo | Intervention Type: DRUG; Name: Indacaterol 150 μg; Assigned to Arm(s): Indacaterol 150 μg-tiotropium 18 μg-placebo, Placebo-indacaterol 150 μg-tiotropium 18 μg, Tiotropium 18 μg-placebo-indacaterol 150 μg | Intervention Type: DRUG; Name: Tiotropium 18 μg; Assigned to Arm(s): Indacaterol 150 μg-tiotropium 18 μg-placebo, Placebo-indacaterol 150 μg-tiotropium 18 μg, Tiotropium 18 μg-placebo-indacaterol 150 μg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Indacaterol 150 μg-tiotropium 18 μg-placebo, Placebo-indacaterol 150 μg-tiotropium 18 μg, Tiotropium 18 μg-placebo-indacaterol 150 μg
D: Arm Label: FF/VI Inhalation Powder NDPI; Type: EXPERIMENTAL; Interventions: Drug: FF/VI 100/25 Inhalation Powder NDPI, Drug: Placebo Inhalation Powder ACCUHALER/DISKUS, Drug: Salbutamol as needed | Arm Label: Fluticasone Propionate/Salmeterol Inhalation Powder; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone Propionate/Salmeterol 250/50 Inhalation Powder ACCUHALER/DISKUS, Drug: Placebo Inhalation Powder NDPI, Drug: Salbutamol as needed | Intervention Type: DRUG; Name: FF/VI 100/25 Inhalation Powder NDPI; Assigned to Arm(s): FF/VI Inhalation Powder NDPI | Intervention Type: DRUG; Name: Fluticasone Propionate/Salmeterol 250/50 Inhalation Powder ACCUHALER/DISKUS; Assigned to Arm(s): Fluticasone Propionate/Salmeterol Inhalation Powder | Intervention Type: DRUG; Name: Placebo Inhalation Powder NDPI; Assigned to Arm(s): Fluticasone Propionate/Salmeterol Inhalation Powder | Intervention Type: DRUG; Name: Placebo Inhalation Powder ACCUHALER/DISKUS; Assigned to Arm(s): FF/VI Inhalation Powder NDPI | Intervention Type: DRUG; Name: Salbutamol as needed; Assigned to Arm(s): FF/VI Inhalation Powder NDPI, Fluticasone Propionate/Salmeterol Inhalation Powder

Answer: A